title: Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study.
abstract: Experimental evidence suggests that vitamin D might play a role in the development of breast cancer. Although the results of case-control studies indicate that circulating 25-hydroxyvitamin D [25(OH)D] is inversely associated with the risk of breast cancer, the results of prospective studies are inconsistent. A case-control study embedded in the European Prospective Investigation into Cancer and Nutrition (EPIC) was carried out comprising 1,391 incident breast cancer cases and 1,391 controls. Multivariable conditional logistic regression models did not reveal a significant overall association between season-standardized 25(OH)D levels and the risk of breast cancer (ORQ4-Q1 [95% CI]: 1.07 [0.85-1.36], ptrend = 0.67). Moreover, 25(OH)D levels were not related to the risks of estrogen receptor positive tumors (ORQ4-Q1 [95% CI]: 0.97 [0.67-1.38], ptrend = 0.90) and estrogen receptor negative tumors (ORQ4-Q1 [95% CI]: 0.97 [0.66-1.42], ptrend = 0.98). In hormone replacement therapy (HRT) users, 25(OH)D was significantly inversely associated with incident breast cancer (ORlog2 [95% CI]: 0.62 [0.42-0.90], p = 0.01), whereas no significant association was found in HRT nonusers (ORlog2 [95% CI]: 1.14 [0.80-1.62], p = 0.48). Further, a nonsignificant inverse association was found in women with body mass indices (BMI) < 25 kg/m(2) (ORlog2 [95% CI]: 0.83 [0.67-1.03], p = 0.09), as opposed to a borderline significant positive association in women with BMI ≥ 25 kg/m(2) (ORlog2 [95% CI]: 1.30 [1.0-1.69], p = 0.05). Overall, prediagnostic levels of circulating 25(OH)D were not related to the risk of breast cancer in the EPIC study. This result is in line with findings in the majority of prospective studies and does not support a role of vitamin D in the development of breast cancer.
authors.affiliation: Division of Cancer Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 581, Heidelberg, Germany.
authors.forename: Tilman
authors.initials: T
authors.lastname: Kühn
authors.forename: Rudolf
authors.initials: R
authors.lastname: Kaaks
authors.forename: Susen
authors.initials: S
authors.lastname: Becker
authors.forename: Piia-Piret
authors.initials: PP
authors.lastname: Eomois
authors.forename: Françoise
authors.initials: F
authors.lastname: Clavel-Chapelon
authors.forename: Marina
authors.initials: M
authors.lastname: Kvaskoff
authors.forename: Laure
authors.initials: L
authors.lastname: Dossus
authors.forename: Anne
authors.initials: A
authors.lastname: Tjønneland
authors.forename: Anja
authors.initials: A
authors.lastname: Olsen
authors.forename: Kim
authors.initials: K
authors.lastname: Overvad
authors.forename: Jenny
authors.initials: J
authors.lastname: Chang-Claude
authors.forename: Annekatrin
authors.initials: A
authors.lastname: Lukanova
authors.forename: Brian
authors.initials: B
authors.lastname: Buijsse
authors.forename: Heiner
authors.initials: H
authors.lastname: Boeing
authors.forename: Antonia
authors.initials: A
authors.lastname: Trichopoulou
authors.forename: Pagona
authors.initials: P
authors.lastname: Lagiou
authors.forename: Christina
authors.initials: C
authors.lastname: Bamia
authors.forename: Giovanna
authors.initials: G
authors.lastname: Masala
authors.forename: Vittorio
authors.initials: V
authors.lastname: Krogh
authors.forename: Carlotta
authors.initials: C
authors.lastname: Sacerdote
authors.forename: Rosario
authors.initials: R
authors.lastname: Tumino
authors.forename: Amalia
authors.initials: A
authors.lastname: Mattiello
authors.forename: Genevieve
authors.initials: G
authors.lastname: Buckland
authors.forename: María-José
authors.initials: MJ
authors.lastname: Sánchez
authors.forename: Virginia
authors.initials: V
authors.lastname: Menéndez
authors.forename: María-Dolores
authors.initials: MD
authors.lastname: Chirlaque
authors.forename: Aurelio
authors.initials: A
authors.lastname: Barricarte
authors.forename: H Bas
authors.initials: HB
authors.lastname: Bueno-de-Mesquita
authors.forename: Fränzel J B
authors.initials: FJ
authors.lastname: van Duijnhoven
authors.forename: Carla H
authors.initials: CH
authors.lastname: van Gils
authors.forename: Marije F
authors.initials: MF
authors.lastname: Bakker
authors.forename: Elisabete
authors.initials: E
authors.lastname: Weiderpass
authors.forename: Guri
authors.initials: G
authors.lastname: Skeie
authors.forename: Magritt
authors.initials: M
authors.lastname: Brustad
authors.forename: Anne
authors.initials: A
authors.lastname: Andersson
authors.forename: Malin
authors.initials: M
authors.lastname: Sund
authors.forename: Nick
authors.initials: N
authors.lastname: Wareham
authors.forename: Kay Tee
authors.initials: KT
authors.lastname: Khaw
authors.forename: Ruth C
authors.initials: RC
authors.lastname: Travis
authors.forename: Julie A
authors.initials: JA
authors.lastname: Schmidt
authors.forename: Sabina
authors.initials: S
authors.lastname: Rinaldi
authors.forename: Isabelle
authors.initials: I
authors.lastname: Romieu
authors.forename: Valentina
authors.initials: V
authors.lastname: Gallo
authors.forename: Neil
authors.initials: N
authors.lastname: Murphy
authors.forename: Elio
authors.initials: E
authors.lastname: Riboli
authors.forename: Jakob
authors.initials: J
authors.lastname: Linseisen
mesh_terms: D001823:Body Composition; D015992:Body Mass Index; D001943:Breast Neoplasms / Q000097:blood* / Q000453:epidemiology*; D016022:Case-Control Studies; D005060:Europe / Q000453:epidemiology; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D009752:Nutritional Status; D011446:Prospective Studies; D011960:Receptors, Estrogen / Q000378:metabolism; D012307:Risk Factors; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D011960:Receptors, Estrogen; D014807:Vitamin D; C104450:25-hydroxyvitamin D
keywords: 25-hydroxyvitamin D; breast cancer; estrogen receptor status; prospective study; vitamin D